# Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor

> **NCT02444390** · NA · COMPLETED · sponsor: **UNICANCER** · enrollment: 150 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **PROCEDURE:** Biopsy

## Key facts

- **NCT ID:** NCT02444390
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-19
- **Primary completion:** 2018-10
- **Final completion:** 2022-07-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2022-09-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02444390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02444390, "Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02444390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*